Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

9.16
-0.1400-1.51%
Post-market: 9.160.00000.00%16:10 EDT
Volume:1.11M
Turnover:10.21M
Market Cap:982.18M
PE:-4.90
High:9.28
Open:9.28
Low:8.86
Close:9.30
52wk High:11.45
52wk Low:3.79
Shares:107.23M
Float Shares:64.81M
Volume Ratio:1.28
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8709
EPS(LYR):-1.9922
ROE:-65.50%
ROA:-36.38%
PB:2.63
PE(LYR):-4.60

Loading ...

Solid Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 03

Solid Biosciences Inc. : H.c. Wainwright Raises Target Price to $25 From $20

THOMSON REUTERS
·
Jun 03

U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty

Reuters
·
Jun 03

Solid Biosciences and Nanomosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics

THOMSON REUTERS
·
Jun 02

Solid Biosciences grants 6,580 RSUs to new hire under inducement plan

Reuters
·
Jun 02

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 02

Solid Biosciences CEO to present at Jefferies Global Healthcare Conference

Reuters
·
Jun 01

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

J.P. Morgan Reaffirms Their Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
May 23

Solid Biosciences Price Target Maintained With a $16.00/Share by Wedbush

Dow Jones
·
May 18

Wedbush Adjusts Price Target on Solid Biosciences to $16 From $17, Maintains Outperform Rating

MT Newswires Live
·
May 13

Solid Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 13

Wedbush Reaffirms Their Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
May 13

Solid Biosciences Q1 EPS $(0.52) Misses $(0.44) Estimate

Benzinga Earnings
·
May 13

Solid Biosciences Q1 net loss widens on higher R&D costs

Reuters
·
May 13

Press Release: Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 13

Solid Biosciences Q1 FY26 net loss widens 44.4% to $56.74 million

Reuters
·
May 13

Solid Biosciences Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
May 11

Solid Biosciences doses part participant in IMPACT DUCHENNE study

TIPRANKS
·
May 08

Solid Biosciences doses first patient in Phase 3 SGT-003 Duchenne trial

Reuters
·
May 07